Avtar S. Dhillon

Filings by Avtar S. Dhillon span 4 companies, the busiest being ONCOSEC MEDICAL Inc, Inovio Pharmaceuticals, Inc. and Arch Therapeutics, Inc. In total, 17 filings cover trades dated from 15 July 2016 to 17 April 2020.

Sales make up the whole of the open-market record (11 sales, €45k). Outside the open market, there are 3 share grants and 3 option exercises.

The newest entry dates from 21 April 2020: a share grant of €18k, in ONCOSEC MEDICAL Inc. The median gap between a trade and its publication by SEC (Form 4) is 10 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.